A global provider of development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
By now, we should all be very familiar with the new Form for providing Product Information (PI) for Australia. Each time you make a change to a PI, be it safety-related or otherwise, you’re required to provide the updated PI to TGA in the new format. The looming deadline for marketed product PIs to be …
The Pointy End of the PI Reformatting Transition PeriodRead More
The appearance of misleading terms and claims on websites and social media has attracted the attention of the TGA. The Therapeutic Goods Administration in Australia (TGA) has advised that fines were imposed via the Federal Court for misleading advertising by Peptide Clinics Australia (Peptide Clinics Pty Ltd), to the tune of $10 million (for breaches …
Consumer Insecurity / Vanity Targeted by TGA – Massive FinesRead More
If you’re advertizing therapeutic goods in Australia in 2019, there’s new legislation that is critical to your successful campaign/s.
We’ve been keeping up to date over the break to ensure we’re ready to assist our clients with all of their commercialization needs around the globe.
